“I enjoy the (NEOMED) researchers. I’ve met them, I’ve talked to them, and I think they are really on top of their game. I love the accessibility of coming to the school any time I want to talk to them and see how they are doing.”
President, RG Smith Company
Living with Parkinson’s Disease
NEOMED Research Supporter
It is estimated that over 3 million Americans have Glaucoma
Health Sciences Research
NEOMED is passionate about advancing health care education, training and practice. In addition, the University conducts health sciences research that focuses on improving the quality of life and overall wellness of Northeast Ohio and beyond.
Community-Based Mental Health
The Community-Based Mental Health Research Focus Area is a collaborative, trans-institutional, and interdisciplinary team of researchers who work with national experts in the area of community mental health.
Christian Ritter, Ph.D., is the director of Community-Based Mental Health Research at NEOMED. Research is targeted toward improving the health and health care of individuals with severe and persistent mental illness.
Diabetes, Obesity & Metabolism
The Community-Based Mental Health Research group is a collaborative, trans-institutional, and interdisciplinary team of researchers who work with national experts in the area of community mental health.
Christian Ritter, Ph.D., is the director of Community-Based Mental Health at NEOMED. Research is targeted toward improving the health and health care of individuals with severe and persistent mental illness.
Hearing disorders of many types begin in the inner-ear, but they have long-term effects on the brain. Within the Hearing Research Focus Area, NEOMED researchers study several hearing and communication health issues ― age-related hearing loss, noise-induced hearing loss, tinnitus, and emotional orders in speech communication – among several others.
Jeff Wenstrup, Ph.D., is the director of the Hearing Research Focus Area at NEOMED. Researchers in this area seek to deepen the understanding of how the central nervous system functions in association with hearing, communication and swallowing; how it is affected by hearing disorders; and how manipulation of the central nervous systems may improve these disorders.
Heart & Blood Vessel Research
Diseases of the heart and blood vessels are the number one cause of death in the U.S. These diseases can lead to heart attacks and strokes and have a tremendous impact on our life expectancy — every 30 seconds an individual in the U.S. dies from heart and vascular diseases; our quality of life — compromising work capacity and lifestyle; and our health care system — costing approximately $50 billion each year. The risk of developing heart and vascular diseases is greatly increased by diabetes, obesity and high blood pressure.
William Chilian, Ph.D., is director of the Heart and Blood Vessel Research Focus Area at NEOMED. Researchers advance the understanding of these diseases with the goal of going beyond stopping their progression and ultimately, curing them. The research is comprised of four clusters of investigators in different scientific areas with a focus on heart and blood vessel diseases: Blood Vessel Growth; Ischemic Heart Disease and Heart Failure; Stem Cells and Regenerative Medicine; and Liver & Metabolic Syndrome.
Bone and tissue regrowth is a way for patients to experience complete recovery from previously debilitating conditions such as arthritis, cancer, osteoporosis and bone fractures.
Fayez Safadi, Ph.D., is director of Musculoskeletal Research Focus Area at NEOMED. Researchers in this area seek to understand the molecular and evolutionary basis of bone and bone diseases, and are focused on developing re-growth processes to address the needs of our aging population.
Neurodegenerative Disease & Aging Research
A collaborative team of researchers within the Neurodegenerative Disease and Aging Research Focus Area, study fundamental and translational research in neurodegeneration and conditions linked to the aging of the brain.
Researchers in this group seek to discover, develop and validate biomarkers and therapeutic approaches for neurodegenerative diseases, including Parkinson’s and Alzheimer’s disease, and glaucoma.